107 related articles for article (PubMed ID: 14592889)
1. Circulating CD4+CD25+ and CD4+CD25- T cells in myasthenia gravis.
Huang Y; Pirskanen R; Ciscombe R; Link H; Lefvert AK
Ann N Y Acad Sci; 2003 Sep; 998():318-9. PubMed ID: 14592889
[No Abstract] [Full Text] [Related]
2. Analysis of CD4+CD25+ cell population in the thymus from myasthenia gravis patients.
Balandina A; Saoudi A; Dartevelle P; Berrih-Aknin S
Ann N Y Acad Sci; 2003 Sep; 998():275-7. PubMed ID: 14592885
[TBL] [Abstract][Full Text] [Related]
3. Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis.
Balandina A; Lécart S; Dartevelle P; Saoudi A; Berrih-Aknin S
Blood; 2005 Jan; 105(2):735-41. PubMed ID: 15454488
[TBL] [Abstract][Full Text] [Related]
4. Circulating and thymic CD4 CD25 T regulatory cells in myasthenia gravis: effect of immunosuppressive treatment.
Fattorossi A; Battaglia A; Buzzonetti A; Ciaraffa F; Scambia G; Evoli A
Immunology; 2005 Sep; 116(1):134-41. PubMed ID: 16108825
[TBL] [Abstract][Full Text] [Related]
5. Increase of circulating CD4+CD25+ T cells in myasthenia gravis patients with stability and thymectomy.
Sun Y; Qiao J; Lu CZ; Zhao CB; Zhu XM; Xiao BG
Clin Immunol; 2004 Sep; 112(3):284-9. PubMed ID: 15308122
[TBL] [Abstract][Full Text] [Related]
6. CD4+ CD25(high) regulatory T cell in childhood ocular myasthenia gravis.
Sakuma H; Katayama A; Saito Y; Komaki H; Nakagawa E; Sugai K; Sasaki M
Brain Dev; 2011 May; 33(5):442-4. PubMed ID: 20797828
[TBL] [Abstract][Full Text] [Related]
7. Does the distribution of circulating CD4+CD28+, CD4+CD25+ T lymphocytes indicate subclinical rejection in patients in the early postoperative state of renal transplantation?
Satoh S; Iinuma M; Kakinuma H; Mitsumori K; Mishina M; Shimoda N; Sato K; Habuchi T; Kato T
Transplant Proc; 2001; 33(7-8):3301-2. PubMed ID: 11750413
[No Abstract] [Full Text] [Related]
8. CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10.
Annacker O; Pimenta-Araujo R; Burlen-Defranoux O; Barbosa TC; Cumano A; Bandeira A
J Immunol; 2001 Mar; 166(5):3008-18. PubMed ID: 11207250
[TBL] [Abstract][Full Text] [Related]
9. CD4+CD25high regulatory cells in human peripheral blood.
Baecher-Allan C; Brown JA; Freeman GJ; Hafler DA
J Immunol; 2001 Aug; 167(3):1245-53. PubMed ID: 11466340
[TBL] [Abstract][Full Text] [Related]
10. Circulating CD4+CD25+ and CD4+CD25+ T cells in myasthenia gravis and in relation to thymectomy.
Huang YM; Pirskanen R; Giscombe R; Link H; Lefvert AK
Scand J Immunol; 2004 Apr; 59(4):408-14. PubMed ID: 15049785
[TBL] [Abstract][Full Text] [Related]
11. T cell receptor gene regulation of experimental autoimmune myasthenia gravis.
Wu B; Shenoy M; Christadoss P
Adv Neuroimmunol; 1994; 4(4):433-45. PubMed ID: 7536604
[No Abstract] [Full Text] [Related]
12. Feasibility of up-regulating CD4(+)CD25(+) Tregs by IFN-γ in myasthenia gravis patients.
Huang S; Wang W; Chi L
BMC Neurol; 2015 Sep; 15():163. PubMed ID: 26347149
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of T cell subsets in myasthenia gravis by anti-T cell monoclonal antibodies].
Zhou M; Chen P; Gong Q; Xu W
Hua Xi Yi Ke Da Xue Xue Bao; 1990 Sep; 21(3):298-300. PubMed ID: 1982666
[TBL] [Abstract][Full Text] [Related]
14. Clinical implication of peripheral CD4+CD25+ regulatory T cells and Th17 cells in myasthenia gravis patients.
Masuda M; Matsumoto M; Tanaka S; Nakajima K; Yamada N; Ido N; Ohtsuka T; Nishida M; Hirano T; Utsumi H
J Neuroimmunol; 2010 Aug; 225(1-2):123-31. PubMed ID: 20472307
[TBL] [Abstract][Full Text] [Related]
15. Circulating CD4+CD25+ T regulatory and natural killer T cells in patients with myasthenia gravis: a flow cytometry study.
Battaglia A; Di Schino C; Fattorossi A; Scambia G; Evoli A
J Biol Regul Homeost Agents; 2005; 19(1-2):54-62. PubMed ID: 16178275
[TBL] [Abstract][Full Text] [Related]
16. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses.
Kingsley CI; Karim M; Bushell AR; Wood KJ
J Immunol; 2002 Feb; 168(3):1080-6. PubMed ID: 11801641
[TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein function in peripheral T lymphocyte subsets of myasthenia gravis patients: clinical implications and influence of glucocorticoid administration.
Tanaka S; Masuda M; Nakajima K; Ido N; Ohtsuka T; Nishida M; Utsumi H; Hirano T
Int Immunopharmacol; 2009 Mar; 9(3):284-90. PubMed ID: 19101657
[TBL] [Abstract][Full Text] [Related]
18. Control of organ-specific autoimmunity by immunoregulatory CD4(+)CD25(+) T cells.
McHugh RS; Shevach EM; Thornton AM
Microbes Infect; 2001 Sep; 3(11):919-27. PubMed ID: 11564440
[TBL] [Abstract][Full Text] [Related]
19. Conversion of CD4+ CD25- cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus.
Liang S; Alard P; Zhao Y; Parnell S; Clark SL; Kosiewicz MM
J Exp Med; 2005 Jan; 201(1):127-37. PubMed ID: 15630140
[TBL] [Abstract][Full Text] [Related]
20. CD25 expression distinguishes functionally distinct alloreactive CD4 CD134 (OX40) T-cell subsets in acute graft-versus-host disease.
Streeter PR; Zhang X; Tittle TV; Schön CN; Weinberg AD; Maziarz RT
Biol Blood Marrow Transplant; 2004 May; 10(5):298-309. PubMed ID: 15111929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
